euportal twitter euportal facebook

Commission and EIB provide loan for CureVac for vaccine development

COVID -19

6.7.2020 – The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a €75 million loan agreement to support the Company’s ongoing development of vaccines against infectious diseases, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections. In addition, the [...]

Read more

Bank On Nature

Prekmurje

The European Commission and the European Investment Bank (EIB) announced on 7 April 2017 the first loan agreement backed by the Natural Capital Financing Facility (NCFF), a financing partnership between the Commission and the EIB supporting nature and climate adaptation projects through tailored loans and investments, backed by an EU guarantee. Today’s agreement will see [...]

Read more